TFFP · Categories · Form 4

TFFP - SEC Form 4 insider transactions

TFF Pharmaceuticals Inc. (TFFP) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for TFFP

• 700d
  President and CEO Weisman Harlan F was granted 27,480 shares, increasing direct ownership by 3% to 842,095 units (SEC Form 4)

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 700d
  Director Lee Catherine Chai-Zon was granted 1,583 shares (SEC Form 4)

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 700d
  Director Mills Robert S was granted 3,165 shares, increasing direct ownership by 6% to 59,145 units (SEC Form 4)

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 700d
  Director Roberts Brandi was granted 3,165 shares, increasing direct ownership by 16% to 23,165 units (SEC Form 4)

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 700d
  Chief Financial Officer Coleman Kirk Allen was granted 10,184 shares, increasing direct ownership by 29% to 45,859 units (SEC Form 4)

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 700d
  Chief Medical Officer Mikhak Zamaneh was granted 10,184 shares, increasing direct ownership by 8% to 145,184 units (SEC Form 4)

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 700d
  Director Rocamboli Stephen was granted 3,165 shares, increasing direct ownership by 9% to 39,165 units (SEC Form 4)

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 700d
  Director King Thomas Braxton was granted 1,583 shares (SEC Form 4)

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 777d
  SEC Form 4 filed by King Thomas Braxton

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 777d
  SEC Form 4 filed by Patane Michael A

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 777d
  SEC Form 4 filed by Lee Catherine Chai-Zon

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 777d
  SEC Form 4 filed by Mills Robert S

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 777d
  SEC Form 4 filed by Roberts Brandi

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 777d
  SEC Form 4 filed by Coleman Kirk Allen

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 777d
  SEC Form 4 filed by Mikhak Zamaneh

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 777d
  SEC Form 4 filed by Rocamboli Stephen

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 777d
  SEC Form 4 filed by Weisman Harlan F

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 906d
  SEC Form 4 filed by King Thomas Braxton

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 917d
  SEC Form 4 filed by Roberts Brandi

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 917d
  SEC Form 4 filed by Mills Robert S

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 917d
  SEC Form 4 filed by Rocamboli Stephen

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 917d
  SEC Form 4 filed by Patane Michael A

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 917d
  SEC Form 4 filed by Lee Catherine Chai-Zon

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1026d
  SEC Form 4: Carlson Capital L P sold $94,433 worth of shares (216,000 units at $0.44)

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1029d
  SEC Form 4: Rocamboli Stephen bought $5,000 worth of shares (20,000 units at $0.25), increasing direct ownership by 125% to 36,000 units

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1029d
  SEC Form 4: Mikhak Zamaneh bought $30,000 worth of shares (120,000 units at $0.25), increasing direct ownership by 800% to 135,000 units

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1029d
  SEC Form 4: Mills Robert S bought $10,000 worth of shares (40,000 units at $0.25), increasing direct ownership by 250% to 55,980 units

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1029d
  SEC Form 4: Coleman Kirk Allen bought $5,000 worth of shares (20,000 units at $0.25), increasing direct ownership by 128% to 35,675 units

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1029d
  SEC Form 4: Roberts Brandi bought $5,000 worth of shares (20,000 units at $0.25)

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1029d
  SEC Form 4: Weisman Harlan F bought $150,000 worth of shares (600,000 units at $0.25), increasing direct ownership by 280% to 814,615 units

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1172d
  SEC Form 4 filed by Coleman Kirk Allen

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1183d
  SEC Form 4: Rocamboli Stephen bought $10,432 worth of shares (13,000 units at $0.80), increasing direct ownership by 433% to 16,000 units

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1184d
  SEC Form 4: Mikhak Zamaneh bought $12,300 worth of shares (15,000 units at $0.82)

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1184d
  SEC Form 4: Weisman Harlan F bought $131,835 worth of shares (150,000 units at $0.88), increasing direct ownership by 232% to 214,615 units

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1184d
  SEC Form 4: Coleman Kirk Allen bought $9,457 worth of shares (12,000 units at $0.79), increasing direct ownership by 327% to 15,675 units

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1256d
  SEC Form 4 filed by Rocamboli Stephen

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1256d
  SEC Form 4 filed by Roberts Brandi

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1256d
  SEC Form 4 filed by Mills Robert S

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1256d
  SEC Form 4 filed by Fletcher Aaron G.L.

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1268d
  SEC Form 4: Weisman Harlan F bought $53,000 worth of shares (50,000 units at $1.06), increasing direct ownership by 342% to 64,615 units

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1280d
  SEC Form 4 filed by Weisman Harlan F

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1294d
  SEC Form 4: Fletcher Aaron G.L. bought $49,990 worth of shares (43,470 units at $1.15), increasing direct ownership by 43% to 143,470 units

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1347d
  SEC Form 4: Thurman Randy H exercised 40,255 shares at a strike of $2.50 and sold $172,694 worth of shares (40,255 units at $4.29)

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1480d
  SEC Form 4: Weisman Harlan F bought $38,182 worth of shares (7,115 units at $5.37), increasing direct ownership by 95% to 14,615 units

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1483d
  SEC Form 4: Fletcher Aaron G.L. bought $538,068 worth of shares (109,600 units at $4.91)

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1483d
  SEC Form 4: Weisman Harlan F bought $11,850 worth of shares (2,500 units at $4.74), increasing direct ownership by 50% to 7,500 units

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1483d
  SEC Form 4: Coleman Kirk Allen bought $7,553 worth of shares (1,675 units at $4.51), increasing direct ownership by 84% to 3,675 units

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1483d
  SEC Form 4: Mattes Glenn R. bought $76,480 worth of shares (16,000 units at $4.78), increasing direct ownership by 80% to 36,000 units

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1483d
  SEC Form 4: Rocamboli Stephen bought $13,620 worth of shares (3,000 units at $4.54), increasing direct ownership by 19% to 18,722 units

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1526d
  SEC Form 4: Fletcher Aaron G.L. bought $3,504,380 worth of shares (542,000 units at $6.47)

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1718d
  SEC Form 4 filed by Cano Christopher

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1727d
  SEC Form 4: Mattes Glenn R. bought $71,000 worth of Common Stock (10,000 units at $7.10), increasing direct ownership by 100% to 20,000 units

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1727d
  SEC Form 4: Coleman Kirk Allen bought $7,300 worth of Common Stock (1,000 units at $7.30), increasing direct ownership by 100% to 2,000 units

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1846d
  SEC Form 4: Fairbairn Malcolm bought $89,500 worth of Common Stock (10,000 units at $8.95)

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1897d
  SEC Form 4: Inc. Therapeutics, Lung sold $10,010,000 worth of Common Stock (715,000 units at $14.00), decreasing direct ownership by 24% to 2,235,000 units

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1909d
  SEC Form 4: Stephen Rocamboli exercised 20,006 units of Common Stock at a strike of $3.16 and sold $337,101 worth of Common Stock (20,006 units at $16.85)

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1909d
  SEC Form 4: Allen Kirk Coleman exercised 5,000 units of Common Stock at a strike of $2.50 and sold $85,250 worth of Common Stock (5,000 units at $17.05)

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1909d
  SEC Form 4: R. Glenn Mattes sold $852,000 worth of Common Stock (50,000 units at $17.04) and exercised 50,000 units of Common Stock at a strike of $2.50

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1936d
  SEC Form 4: R. Glenn Mattes exercised 40,000 units of Common Stock at a strike of $2.50 and sold $672,800 worth of Common Stock (40,000 units at $16.82)

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)
• 1936d
  SEC Form 4: Allen Kirk Coleman exercised 5,000 units of Common Stock at a strike of $2.50 and sold $84,100 worth of Common Stock (5,000 units at $16.82)

  4 - TFF Pharmaceuticals, Inc. (0001733413) (Issuer)

Other TFFP categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends